REGISTERED NUMBER:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Abbreviated Unaudited Accounts |
|
for the Year Ended 31st March 2016 |
|
for |
|
DRUGLAB118 LTD |
REGISTERED NUMBER:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Abbreviated Unaudited Accounts |
|
for the Year Ended 31st March 2016 |
|
for |
|
DRUGLAB118 LTD |
DRUGLAB118 LTD (REGISTERED NUMBER: 08447515) |
|
|
|
|
|
|
Contents of the Abbreviated Accounts |
for the Year Ended 31st March 2016 |
|
|
|
|
Page |
|
Company Information | 1 |
|
Abbreviated Balance Sheet | 2 |
|
Notes to the Abbreviated Accounts | 4 |
|
Accountants' Report | 5 |
DRUGLAB118 LTD |
|
Company Information |
for the Year Ended 31st March 2016 |
|
|
|
|
|
|
|
DIRECTORS: |
|
|
|
|
|
|
|
|
REGISTERED OFFICE: |
|
|
|
|
|
|
|
|
|
REGISTERED NUMBER: |
|
|
|
|
|
|
ACCOUNTANTS: |
|
|
|
|
|
DRUGLAB118 LTD (REGISTERED NUMBER: 08447515) |
|
Abbreviated Balance Sheet |
31st March 2016 |
|
31/3/16 | 31/3/15 |
Notes | £ | £ |
CURRENT ASSETS |
Debtors |
|
|
Cash at bank and in hand |
|
|
|
|
CREDITORS |
Amounts falling due within one year |
|
|
NET CURRENT LIABILITIES | ( |
) | ( |
) |
TOTAL ASSETS LESS CURRENT
LIABILITIES |
( |
) |
( |
) |
|
CAPITAL AND RESERVES |
Called up share capital | 2 |
|
|
Profit and loss account | ( |
) | ( |
) |
SHAREHOLDERS' FUNDS | ( |
) | ( |
) |
DRUGLAB118 LTD (REGISTERED NUMBER: 08447515) |
|
Abbreviated Balance Sheet - continued |
31st March 2016 |
|
|
|
|
|
|
The directors acknowledge their responsibilities for: |
(a) |
ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies
Act 2006 and |
(b) |
preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of
each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company. |
|
|
|
|
The financial statements were approved by the Board of Directors on
by: |
|
|
|
|
|
|
|
DRUGLAB118 LTD (REGISTERED NUMBER: 08447515) |
|
Notes to the Abbreviated Accounts |
for the Year Ended 31st March 2016 |
|
1. | ACCOUNTING POLICIES |
|
Basis of preparing the financial statements |
The accounts have been prepared under the going concern basis of accounting. At the balance sheet date the |
company's liabilities exceeded its assets by £137,375. The Directors have confirmed that they will support the |
company as required. In addition the company commenced trading activities in the subsequent year and the |
Directors believe that this will take the balance sheet into a positive position. |
|
Accounting convention |
The financial statements have been prepared under the historical cost convention and in accordance with the |
Financial Reporting Standard for Smaller Entities (effective January 2015). |
|
Turnover |
Turnover represents net invoiced sales of goods, excluding value added tax, except in respect of service contracts |
where turnover is recognised when the company obtains the right to consideration. |
|
Deferred tax |
Deferred tax is provided on the liability method to take account of timing differences between the treatment of |
certain items for accounts purposes and their treatment for tax purposes. Tax deferred is accounted for in respect |
of all material timing difference. The company has not adopted a policy of discounting deferred tax assets and |
liabilities. |
|
2. | CALLED UP SHARE CAPITAL |
|
Allotted, issued and fully paid: |
Number: | Class: | Nominal | 31/3/16 | 31/3/15 |
value: | £ | £ |
|
Ordinary A | £1 |
|
|
|
|
Accountants' Report to the Board of Directors |
on the Unaudited Financial Statements of |
Druglab118 Ltd |
|
The following reproduces the text of the report prepared for the directors in respect of the company's annual |
unaudited financial statements, from which the unaudited abbreviated accounts (set out on pages two to four) |
have been prepared. |
|
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the |
financial statements of Druglab118 Ltd for the year ended 31st March 2016 which comprise the Profit and Loss Account, |
the Balance Sheet, and the related notes from the company's accounting records and from information and explanations |
you have given us. |
|
As a practising member firm of the Association of Chartered Certified Accountants, we are subject to its ethical and other professional requirements which are detailed at http://www.accaglobal.com/rulebook. |
|
This report is made solely to the Board of Directors of Druglab118 Ltd, as a body, in accordance with the terms of our engagement letter dated 19th August 2015. Our work has been undertaken solely to prepare for your approval the financial statements of Druglab118 Ltd and state those matters that we have agreed to state to the Board of Directors of Druglab118 Ltd, as a body, in this report in accordance with the requirements of the Association of Chartered Certified Accountants as detailed at http://www.accaglobal.com/factsheet163. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and its Board of Directors, as a body, for our work or for this report. |
|
It is your duty to ensure that Druglab118 Ltd has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and loss of Druglab118 Ltd. You consider that Druglab118 Ltd is exempt from the statutory audit requirement for the year. |
|
We have not been instructed to carry out an audit or a review of the financial statements of Druglab118 Ltd. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements. |
|
|
|
|
|
|
|
|
|
|
|
|
|
22nd December 2016 |